Exercise Intensity and Type 2 Diabetics

Type 2 Diabetes Clinical Trial

— EIT2D  

Official title:

Effects of Exercise Intensity on 24-h Ambulatory Blood Pressure in Type 2 Diabetics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01356953
• Other study ID #: MORAIS0132008
• Status: Completed
• Phase: N/A
• First received: May 10, 2011
• Last updated: May 19, 2011
• Start date: October 2008
• Est. completion date: August 2009

Study information

• Verified date: September 2008
• Source: Catholic University of Brasília
• Contact: n/a
• Is FDA regulated: No
• Health authority: Brazil: Physical Education Department
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if a single session of aerobic exercise effectively controls the blood pressure (BP) of individuals with type 2 diabetes mellitus (T2DM) over the 24h of post-exercise period, and the effects of intensity of aerobic exercise on these BP responses.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: August 2009
• Est. primary completion date: July 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 45 Years to 70 Years

Eligibility

Inclusion Criteria:

• sedentary

• a diagnosis of T2DM for at least one year

• glycemic control through nutrition and/or medication

Exclusion Criteria:

• be not under use of exogenous insulin and do not present chronic complications such as diabetic foot

• nephropathy

• retinopathy

• neuropathies and cardiovascular diseases

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Type 2 Diabetes

Intervention

Other:
• Aerobic exercise
Intensity of aerobic exercise

Locations

Country	Name	City	State
Brazil	Catholic University of Brasilia	Taguatinga

Sponsors (2)

Lead Sponsor	Collaborator
Catholic University of Brasília	Conselho Nacional de Desenvolvimento Científico e Tecnológico

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood Pressure - Ambulatory blood pressure monitoring (ABPM)		Participants will be followed for the duration of experimental tests, an expected average of 4 weeks	Yes